Is surgery recommended for Liver Cancer and when

Surgery for Liver Cancer: When It's Recommended

Surgery can be an important treatment option for liver cancer (hepatocellular carcinoma or HCC), but whether it's recommended depends on several specific factors about your cancer and your liver health.

When Surgery IS Recommended

According to the NCCN Guidelines for Hepatocellular Carcinoma, partial hepatectomy (surgical removal of part of the liver) is considered a potentially curative treatment when:

Optimal Tumor Characteristics:

• Single tumor of any size with no evidence of major vascular invasion (cancer spreading into blood vessels)
• Limited multifocal disease (a few tumors in specific locations) may be considered, though this is more controversial

Optimal Liver Function:

• Your liver must have adequate function, generally measured by a Child-Turcotte-Pugh (CTP) Class A score (a scoring system that evaluates liver health)
• Absence of significant portal hypertension (high blood pressure in the portal vein, which carries blood through the liver)
• In highly selected patients with mild portal hypertension and normal liver function tests, limited resection may still be possible

Adequate Future Liver Remnant (FLR):

• The remaining liver after surgery must be large enough to function properly
• NCCN Guidelines recommend at least 20% of total liver volume in patients without cirrhosis
• At least 30-40% of total liver volume in patients with cirrhosis and CTP Class A function

Surgical Outcomes

For well-selected patients, surgery can offer meaningful benefits:

• 5-year survival rates exceed 50% for patients undergoing liver resection
• For selected patients with preserved liver function and early-stage HCC, 5-year survival rates reach approximately 70%
• Modern surgical techniques have low operative mortality (≤5%) in experienced centers

However, recurrence is common—recurrence rates at 5 years exceed 70%, meaning cancer can return in the remaining liver or develop as new tumors.

When Surgery Is Controversial

Surgery may be considered but is more debated for:

• Limited multifocal disease (multiple tumors)
• Major vascular invasion (cancer in major blood vessels)

In these situations, 5-year survival rates are lower (around 20-35%), and your multidisciplinary team will carefully weigh risks versus benefits.

When Surgery Is NOT Recommended

Surgery is generally not recommended if you have:

• Significantly impaired liver function (CTP Class B or C)
• Evidence of clinical decompensation (your liver is failing)
• Inadequate future liver remnant (not enough healthy liver would remain)
• Major vascular invasion (in most cases)
• Extrahepatic metastases (cancer spread outside the liver)

Important Preoperative Assessments

Before surgery, your team will evaluate:

1. Liver function tests - Including albumin levels, bilirubin, and other markers
2. Imaging studies - CT or MRI to map tumor location, size, and relationship to blood vessels
3. Portal hypertension assessment - To determine if high blood pressure in liver vessels is present
4. Future liver remnant calculation - Precise measurement of how much healthy liver will remain

Special Consideration: Portal Vein Embolization (PVE)

For patients with chronic liver disease being considered for major surgery, preoperative portal vein embolization should be considered. This is a minimally invasive procedure that redirects blood flow to encourage the remaining liver to grow larger before surgery, reducing the risk of liver failure after resection.

Questions to Ask Your Healthcare Team

1. Is my tumor resectable? (Can it be safely removed?)
2. What is my liver function score (CTP or ALBI grade), and what does this mean for surgery?
3. How much of my liver would remain after surgery, and is this adequate?
4. Do I have portal hypertension, and how does this affect surgical candidacy?
5. Would portal vein embolization help prepare me for surgery?
6. What are the specific risks and benefits of surgery versus other treatment options for my situation?
7. If I'm not a surgical candidate now, could I become one after other treatments?

The Multidisciplinary Approach

According to NCCN Guidelines, all patients with HCC should be carefully evaluated by an experienced multidisciplinary team including hepatologists, surgeons, interventional radiologists, medical oncologists, and pathologists. This is because HCC management is complex—the underlying liver disease significantly impacts treatment decisions and outcomes.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.